These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Proceedings: Local Corynebacterium parvum therapy in early breast cancer. Ackroyd NW; Boak JL Br J Surg; 1976 Aug; 63(8):659. PubMed ID: 953485 [No Abstract] [Full Text] [Related]
3. Local Corynebacterium parvum therapy in early breast cancer: a pilot study. Boak JL Clin Oncol; 1978 Sep; 4(3):235-42. PubMed ID: 750126 [No Abstract] [Full Text] [Related]
4. A phase I study of a multi-modal schedule with Corynebacterium parvum. McIntosh IH; Thynne GS; Bejrajati P; Walsh G; Greening WP Dev Biol Stand; 1977 Apr 13-15; 38():477-82. PubMed ID: 344102 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo effects of Corynebacterium parvum on lymphocyte transformation. Fisher RA Dev Biol Stand; 1977 Apr 13-15; 38():461-6. PubMed ID: 608539 [TBL] [Abstract][Full Text] [Related]
6. A survey of patients' reactions to intravenous Corynebacterium parvum therapy. Palmer BV; Walsh G; Smedley P; McIntosh IH; Greening WP Dev Biol Stand; 1977 Apr 13-15; 38():529-33. PubMed ID: 608547 [TBL] [Abstract][Full Text] [Related]
8. Corynebacterium parvum and metastatic breast cancer. Haskell CM; Sarna GP; Liu PY Br J Cancer; 1982 May; 45(5):794-5. PubMed ID: 7044404 [No Abstract] [Full Text] [Related]
9. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice. Scott MT J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560 [TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer. Webster DJ; Chare MJ; Baum M Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540 [TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine. Hortobagyi GN; Yap HY; Wiseman CL; Blumenschein GR; Buzdar AU; Legha SS; Gutterman JU; Hersh EM; Bodey GP Cancer Treat Rep; 1980 Jan; 64(1):157-9. PubMed ID: 6991103 [TBL] [Abstract][Full Text] [Related]
14. Corynebacterium parvum as an immunotherapeutic anticancer agent. Scott MT Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441 [No Abstract] [Full Text] [Related]
15. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum. Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086 [No Abstract] [Full Text] [Related]
16. The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. James K; Clunie GJ; Woodruff MF; McBride WH; Stimson WH; Drew R; Catty D Br J Cancer; 1975 Sep; 32(3):310-22. PubMed ID: 61040 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience in the use of C. parvum in the treatment of locally advanced carcinoma of the breast. Chare MJ; Webster DJ; Baum M Dev Biol Stand; 1977 Apr 13-15; 38():495-9. PubMed ID: 344104 [TBL] [Abstract][Full Text] [Related]
18. Proceedings: The effect of Corynebacterium parvum on a subcutaneous tumour. Jones PD; Sadler TE; Castro JE Br J Surg; 1976 Aug; 63(8):659-60. PubMed ID: 953487 [No Abstract] [Full Text] [Related]
19. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum. Hamilton DN; Bell PR Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648 [No Abstract] [Full Text] [Related]
20. [Comparison of two nonspecific immune stimuli in antiblastic chemotherapy]. Bianucci P; Pastorino G Arch Sci Med (Torino); 1980; 137(1):33-40. PubMed ID: 7458652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]